Myriad Neuroscience--formerly Assurex Health--is a personalized medicine company that specializes in pharmacogenomics and is dedicated to helping healthcare providers get the genetic information they need to determine the right medication for individual patients suffering from neuropsychiatric and other medical conditions. Myriad Neuroscience’s proprietary technology is based on pharmacogenomics—the study of the genetic factors that influence an individual’s response to drug treatments—as well as evidence-based medicine and clinical pharmacology. The GeneSight® test was developed in the Myriad Neuroscience clinical laboratory and is based on patented technology licensed from two world renowned medical centers, Mayo Clinic and Cincinnati Children’s Hospital Medical Center, who continue to be research collaborators. The company was founded in 2006 and is located in Mason, OH.